Clinical Trial Update: Effect of PMSCs and Their Secretome for the Treatment of GvHD [Phase 3]

View source ↗

Summary

A Phase 3 study evaluated placental mesenchymal stem cells (PMSCs) and their secretome for the treatment of graft-versus-host disease; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• PMSCs (Placental mesenchymal stem cells)

Snippet

Sponsor: Tabriz University of Medical Sciences | Conditions: GVHD | Phase 3 | Status: COMPLETED